Comparison of Mirror Therapy and Modified Constrain Induced Movement Therapy on Risk of Fall, Balance and Gait in Stroke

Launched by RIPHAH INTERNATIONAL UNIVERSITY · Aug 3, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at two different types of therapy—Mirror Therapy and Modified Constraint Induced Movement Therapy—to see how they affect balance, walking, and the risk of falling in patients who have had a stroke. The goal is to understand which therapy might help stroke survivors improve their mobility and stability better.

To participate, individuals must be between 21 and 70 years old and have experienced a stroke that has left them with weakness on one side of their body (this is called hemiplegia). They should have a moderate level of understanding and be able to engage in the therapy. However, those with significant depression, certain heart or lung conditions, or other serious neurological issues may not qualify. Participants will undergo therapy sessions and will be monitored to see how their balance and walking improve over time. If you or a loved one are interested in joining this study, it could be a chance to explore new ways to regain mobility after a stroke.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • A Hemiplegia due to unilateral stroke
• • Sub-acute and chronic stroke
• • Stroke survivors between 21 and 70 years old will be recruited
• • Both genders
• • NIH Stroke scale below 20
• • Mini-Mental State Examination above 24
• • Function in Sitting Test (FIST) above 42/56
• Exclusion Criteria:
• • Patients with depression who will be unable to cooperate during treatment
• • Patients who cannot perform the active movement of limb due to prestroke muscoskeletal problems
• • Cardiopulmonary diseases which could hinder their ability to participate in rehabilitation
• • Spasticity of Modified Ashworth Scale (MAS) II or higher
• • Patients with Any neuron disease and Patients with lower-limb impairment caused by other neurological diseases or inability to comply with study protocol will be excluded.
• • Visual and auditory abnormalities